unrelated to PLA 2 , which makes it difficult to define the contribution of iPLA 2 to specific functions. In previous work we pioneered the use of antisense technology to decrease cellular iPLA 2 activity as an alternative approach to study iPLA 2 functions.
In the present study we have followed the opposite strategy and have prepared U937 cells that exhibit enhanced iPLA 2 activity by stably expressing a plasmid containing iPLA 2 cDNA. Compared with control cells, the iPLA 2 -overexpressing U937 cells show elevated responses to hydrogen peroxide with regard to both arachidonic acid mobilization and incorporation of the fatty acid into phospholipids, thus providing additional evidence for the key role that iPLA 2 plays in these events. Long-term exposure of the cells to hydrogen peroxide results in cell death by apoptosis, and this process is accelerated in the iPLA 2 -overexpressing cells. Increased phospholipid hydrolysis and fatty acid release also occur in these cells. Unexpectedly however, abrogation of U937 cell iPLA 2 activity by either methyl arachidonyl fluorophosphonate or an antisense oligonucleotide does not delay or decrease the extent of apoptosis induced by hydrogen peroxide. These results indicate that although iPLA 2 -mediated phospholipid hydrolysis occurs during apoptosis, iPLA 2 may actually be dispensable for the apoptotic process to occur. Thus, beyond a mere destructive role, iPLA 2 may be playing other roles during apoptosis. Phospholipase A 2 s (PLA 2 ) 1 constitute a diverse group of enzymes whose common feature is to hydrolyze the fatty acid at the sn-2 position of phospholipids. Several mammalian intracellular and extracellular PLA 2 s have been characterized in recent years and classified into fourteen group types on the basis of sequence data [1, 2] .
Attending to their biochemical characteristics, the PLA 2 s are generally grouped into three major subfamilies, namely secreted PLA 2 s (sPLA 2 ), cytosolic Ca 2+ -dependent PLA 2 (cPLA 2 ), and cytosolic Ca 2+ -independent PLA 2 (iPLA 2 ) [1] [2] [3] [4] [5] [6] . sPLA 2 s are extracellular, low molecular mass enzymes that require millimolar Ca 2+ concentrations for activity. cPLA 2 , specifically the α isoform, is an intracellular enzyme that plays a pivotal role in receptor-coupled arachidonic acid (AA) release and prostaglandin production. Whereas cPLA 2 α has a striking selectivity for AAcontaining phospholipids, sPLA 2 s do not exhibit acyl chain specificity. -independent cytosolic enzymes whose functional role(s) in cells has recently gained interest [7, 8] . Among the iPLA 2 s, the better studied is the one classified as Group VIA. This is an 85-kDa enzyme that shows no fatty acid selectivity and is potently and irreversibly inhibited by bromoenol lactone (BEL) [7, 8] .
Evidence suggests that Group VIA iPLA 2 is directly involved in maintaining the homeostatic levels of lysophosphatidylcholine (lysoPC) in resting cells [9] . Since lysoPC is the main acceptor of free AA for its incorporation into phospholipid pools [10] , Group VIA iPLA 2 has been implicated in phospholipid fatty acyl chain deacylation/reacylation reactions (i.e. the Lands cycle). In these reactions, a phospholipid containing a saturated fatty acid in the sn-2 position is cleaved by Group VIA iPLA 2 , and the resulting lysophospholipid acceptor is acylated by CoAdependent acyl transferases with a polyunsaturated fatty acid such as AA. This proposal, based on the demonstration that inhibition of cellular iPLA 2 by BEL or a specific antisense oligonucleotide blocks AA incorporation, was originally described in P388D 1 macrophages [11, 12] and later confirmed by others in a number of mammalian cells [13] [14] [15] .
It seems likely however, that neither Group VIA iPLA 2 is the only enzyme involved in maintaining homeostatic lysophospholipid levels [16] nor is that the only cellular function of Group VIA iPLA 2 in cells. Recent evidence has implicated this enzyme in the destruction of membrane phospholipid subsequent to the cells entering apoptosis, resulting in the liberation of various free fatty acids to the extracellular medium [17] [18] [19] . Another instance wherein iPLA 2 -mediated phospholipolysis occurs in a seemingly receptor-uncontrolled manner is during oxidative stress [20, 21] . Finally, cells from schizophrenic patients have been reported to exhibit a constitutively elevated phospholipid fatty acid turnover, which appears to be mediated by an iPLA 2 -like activity [22] .
To further expand our investigations on cellular functions of Group VIA iPLA 2 in human U937 cells [9, 16, 20, 23, 24] , we have prepared stably transfected cells that overexpress Group VIA iPLA 2 . Utilizing this strategy, we have re-assessed the role of iPLA 2 in oxidant-induced AA release and incorporation into phospholipids, and extended our studies to the role of iPLA 2 in oxidant-induced apoptosis.
EXPERIMENTAL PROCEDURES
Materials. [5,6,8,9,11,12,14, cells) was transfected by electroporation at 270 V (975 µF) using a Gene Pulser II electroporator (Bio-Rad). To select for the transfected cells, they were incubated in medium containing 1 mg/ml geneticin. To obtain the transfectants stably expressing Group VIA iPLA 2 , the transfected cells were cloned by limiting dilution in medium containing 300 µg/ml geneticin. After two weeks, wells containing a single colony were chosen for further expansion and the iPLA 2 expression was analyzed by immunoblot and measurement of iPLA 2 activity. The clones were always grown in medium containing 300 µg/ml geneticin.
Immunoblot analyses. Cells were lysed in an ice-cold lysis buffer, and 15 µg of cellular protein from each sample were separated by standard 10% SDS-PAGE and transferred to nitrocellulose membranes. Dilution of both primary and secondary antibodies was made in phosphate-buffered saline containing 0.5% defatted dry milk and 0.1% Tween 20. After 1 h incubation with primary antibody at 1:1000, blots were washed 3 times and an anti-rabbit secondary peroxidase-conjugated antibody was added for another h. Immunoblots were developed using the Amersham ECL system. iPLA 2 assay -Briefly, aliquots of U937 cell homogenates were incubated for 2 h at 37°C in 100 mM Hepes (pH 7.5) containing 5 mM EDTA and 100 µM labeled phospholipid substrate (1-palmitoyl-2-[ Antisense oligonucleotide treatments. The iPLA 2 antisense oligonucleotide utilized in this study has been described in previous studies from our laboratory [12, 20, 23, 24] . The iPLA 2 antisense sequence corresponds to nucleotides 59-78 in the murine group VIA iPLA 2 sequence, which is conserved in human group VIA iPLA 2 [26, 27] . The antisense or sense oligonucleotides were mixed with lipofectamine, and complexes were allowed to form at room temperature for 10-15 min. The complexes were then added to the cells, and the incubations were allowed to proceed under standard cell culture conditions. The final concentrations of oligonucleotide and lipofectamine were 1 µM and 10 µg/ml, respectively. Oligonucleotide treatment and culture conditions were not toxic for the cells as assessed by the Trypan blue dye exclusion assay and by quantitating adherent cell protein.
Conditions for the use of a human cPLA 2 antisense oligonucleotide were taken from Tomassini and Cantoni [28] . The oligonucleotides used were: antisense: 5'-TAC AGT AAA TAT CTA GGA ATG-3'; and sense (random sequence of the antisense bases): 5'-CCT ACT GAG GGT ACG GTA CAT-3'). The oligonucleotides were phosphorothioate-modified (MWG Biotech, Ebersberg, Germany). The U937 cells were washed twice with serum-free medium and seeded at a cell density of 10 6 per ml in serum-free medium for 6 h in the absence of presence of the oligonucleotides 
RESULTS

Characterization of U937 cells overexpressing Group VI iPLA 2 -Transfection
of U937 cells with a plasmid containing mouse Group VIA iPLA 2 followed by selection of geneticin-resistant clones resulted in the isolation of a stably transfected clone expressing a 3-4-fold increase in iPLA 2 activity as compared to control cells transfected with an empty plasmid (Fig. 1A) . The stably transfectants also showed increased levels of an 85 kDa protein that was recognized by the anti-iPLA 2 antibody from Cayman (Fig. 1A, inset ). In addition, the stably transfected cells also exhibited a had been replaced by Ala. These data appear to suggest that large increases or decreases in the intracellular iPLA 2 activity content are injurious for the U937 cells, which in turn highlight the importance that this class of enzymes may have in the regulation of homeostatic phospholipid metabolism.
When exposed to H 2 O 2 , U937 macrophage-like cells have been shown to liberate fatty acids, including AA, in a process that appears to depend on iPLA 2 [20] . Fig. 2 shows that the iPLA 2 -overexpressing cells liberated more AA than did control cells when exposed to H 2 O 2. Basal release (i.e, that determined in the absence of H 2 O 2 ) was also increased in the iPLA 2 -overexpressing cells. As a control for these experiments, the effect of concanavalin A on AA release from these cells was also investigated. Concanavalin A is known to signal to AA release in U937 cells by directly activating the cPLA 2 , and the iPLA 2 is not involved [20] . In accordance with these previous findings, iPLA 2 overexpression did not result in an increased AA release response of the cells to concanavalin A (data not shown). Thus, iPLA 2 overexpression does not impact on cellular functions that do not depend on iPLA 2 . To further strengthen the lack of involvement in H 2 O 2 -induced AA mobilization, experiments were conducted in which cPLA 2 expression was knocked out by antisense technology (Fig. 3) . Only partial inhibition of cPLA 2 could be achieved (38 ± 5% inhibition as assessed by immunoblot, Fig. 3 inset) , which was not unexpected, given the high levels of cPLA 2 that the U937 cells are known to express [29, 30] .
Despite such a low inhibition, we were still able to detect significant inhibition of the Con A-induced AA release (Fig. 3) . Importantly, parallel measurement of the H 2 O 2 -induced AA mobilization showed no detectable effect (Fig. 3) . These data, along with our previous data showing no inhibition of the H 2 O 2 -induced AA release by the cPLA 2 -specific inhibitor pyrrophenone [20] , strengthen the lack of a role for cPLA 2 in oxidant-induced AA mobilization in U937 cells.
Role of iPLA 2 in AA incorporation into U937 cell phospholipids exposed to H 2 O 2 -Rather than reflecting enzyme activation per se, iPLA 2 -mediated fatty acid release in response to H 2 O 2 is thought to occur because of a facilitated interaction of the enzyme with its substrate, secondary to H 2 O 2 -induced membrane oxidation [20] . In the first series of experiments, we assayed H 2 O 2 -induced AA release in the presence of thimerosal, a well known inhibitor of fatty acyl-CoA synthetases and hence, of fatty acid incorporation into phospholipids [33, 34] . Figure 4 shows that thimerosal did not affect AA release on its own, but markedly augmented [ Further proof to the above view was obtained when AA incorporation was studied in the iPLA 2 stably transfectants which, as indicated above, present higher amounts of lysoPC to serve as the acyl acceptors. The iPLA 2 overexpressing cells incorporated more exogenous AA into phospholipids than did control cells transfected with an empty vector (Fig. 6) . Moreover, when the AA incorporation experiments were conducted in the presence of H 2 O 2 , additional increases were observed again in both the untrasfected and the iPLA 2 -overexpressing cells (Fig. 6 ).
All these increases were significantly blunted by BEL (~40% inhibition), confirming the involvement of iPLA 2 in the response (Fig. 7) . It should be noted however, that the fact that BEL does not completely blunt AA incorporation indicates that there are other pathways in addition to iPLA 2 that may significantly contribute to overall AA incorporation into cellular phospholipids [16] . Interestingly, pyrrophenone, a specific cPLA 2 inhibitor, failed to exert any significant effect on the response (not shown). [35, 36] , and there is evidence that unesterified fatty acids such as AA inside the cells can signal apoptosis [37] . Since iPLA 2 is responsible for liberating fatty acids in response to H 2 O 2 , the possibility arises that iPLA 2 may be a key signaler of H 2 O 2 -induced apoptosis. Figure 8 shows that almost 40% of the U937 cells exposed to 500 µM H 2 O 2 underwent apoptosis at 20 h, as measured by the annexin-V-FITC assay. Importantly, the fraction of cells undergoing apoptosis was doubled if iPLA 2 overexpressing cells were used (Fig. 8) . As a control for these experiments we used BEL, which is known to induce apoptosis in U937 cells in an iPLA 2 -independent manner [24] . More than 90% of the cell population underwent apoptosis in the presence of BEL and this happened in both control and iPLA 2 -overexpressing U937 cells (Fig. 8) . Thin-layer chromatographic analyses of the radioactivity accumulating in the extracellular medium revealed that more than 80% of it corresponded to free fatty acid. Collectively, data in Figs. 8 and 9 suggest that iPLA 2 participates in H 2 O 2 -induced apoptosis of U937 cells, and promotes destruction of membrane phospholipid .
The effect of iPLA 2 inhibition on H 2 O 2 apoptosis was assayed next. The cells were incubated with MAFP, a dual cPLA 2 /iPLA 2 inhibitor that, unlike BEL, does not induce apoptosis of the U937 cells on its own [24] . Preliminary experiments carried out with the specific cPLA 2 inhibitor pyrrophenone had shown no effect of this compound on H 2 O 2 -induced apoptosis, which rules out a role for cPLA 2 in the process, in agreement with previous reports [17, 18] . Unexpectedly, incubating the cells for 6, 8 or 20 h with 10-25 µM MAFP ---concentrations which we have previously shown to completely inhibit cellular iPLA 2 activity [24] --also failed to decrease the extent of H 2 O 2 -induced apoptosis, as measured by the annexin V-FITC surface binding assay (Fig. 10A) . In agreement with these data, U937 cells made deficient in iPLA 2 by antisense treatment exhibited no decreased apoptosis in response to H 2 O 2 (Fig. 10B) . These results suggest that, although iPLA 2 -mediated phospholipid breakdown does occur during H 2 O 2 -induced apoptosis, the apoptotic process itself still can occur in the absence of iPLA 2 . DISCUSSION H 2 O 2 is an oxidant generated in large quantities by phagocyte cells by the action of superoxide dismutase on superoxide anion. Excessive accumulation of H 2 O 2 is known to cause lipid peroxidation, which may compromise cellular function and, ultimately leading to cytotoxicity. H 2 O 2 is widely used as an oxidant stressor for the study of oxidation-induced signaling events in different cell models. In previous work, we have described the molecular mechanism for fatty acid mobilization during H 2 O 2 -induced oxidative damage in U937 cells and found an unexpected role for Group VIA iPLA 2 as a main participant in the process [20] . Probably by increasing the amount of lipid peroxides at the membrane, the oxidant was found to increase the accessibility/susceptibility of iPLA 2 towards its substrate, which resulted in increased fatty acid release [20] . From a biochemical viewpoint this iPLA 2 role is striking since, under true activation conditions --i.e. those involving the activation of receptor-dependent or -independent intracellular signaling cascades--, there is general recognition that cPLA 2 α, not iPLA 2 , is an absolute requirement for AA mobilization in phagocyte cells. While inhibition of cPLA 2 α strongly blunts receptor-induced AA mobilization in phagocytes, inhibition of iPLA 2 by BEL does not generally affect the response [20, [38] [39] [40] [41] [42] .
iPLA 2 involvement in oxidant-induced phospholipid hydrolysis has also been recognized to occur in uterine stromal cells [21] and, more recently, in astrocytes as well [43] . Interestingly however, in cells such as alveolar macrophages [31] and vascular smooth muscle cells [32] , oxidant-induced AA mobilization was found to result from impairment of fatty acid incorporation into phospholipids. Given the key role that iPLA 2 appears to play in AA deacylation/reacylation reactions in immunoinflammatory cells [7, 8] , it was of interest to assess the effect of H 2 O 2 on the AA incorporation mechanisms of U937 macrophage-like cells. Initial studies were carried out with thimerosal, an organometalic compound that blocks AA reacylation but spares deacylation via PLA 2 [33, 34] . This compound markedly enhanced the Thus, the biochemical significance of the AA incorporation data in the H 2 O 2 -treated cells is that not all of the AA released from phospholipids by iPLA 2 will be available for further metabolism. Rather, a significant portion of free AA will be incorporated back into phospholipids, limiting in this way the amount of free AA available for further metabolic reactions.
Control of the intracellular level of lysophospholipid acceptors utilized for incorporation of AA into phospholipids is one of the earliest proposed roles for iPLA 2 in phagocyte cells. This role was demonstrated by studies in which iPLA 2 activity was reduced in cells by either pharmacological or antisense inhibition approaches [7, 8, 11, 12] . In the current study we have employed a third different approach, which is the opposite of the other two previously employed. We have prepared cells that stably overexpress iPLA 2 to confirm previous functional roles proposed for the enzyme, and to study new ones. As would be expected from the model discussed above, the iPLA 2 overexpressing cells exhibit a significantly higher capacity to incorporate AA into phospholipids than control cells. Also, the iPLA 2 overexpressing cells mobilize larger quantities of free AA in response to H 2 O 2 . Thus, these results provide new evidence for the key role of iPLA 2 in mediating phospholipid hydrolysis during oxidative stress by H 2 O 2 . In turn, the results provide additional evidence for the key role of iPLA 2 in regulating the intracellular levels of lysoPC to be used for fatty acid incorporation via the Lands cycle. Studies on whether lysoPC levels limit the initial rate of AA incorporation into phospholipids in cells not of the phagocytic lineage have also recently been carried out. In pancreatic islet cells, the steady-state levels of lysoPC appear to be so high that even after acute inhibition of endogenous iPLA 2 , the cells still retain at least 80% of their initial lysoPC content [44] . Thus the initial rate of AA incorporation into islet phospholipids is not altered, suggesting that in these cells the iPLA 2 is not required for the initial AA incorporation into phospholipids. Nevertheless, it should be noted that islet iPLA 2 is estimated to provide at least 20% of the very high lysoPC levels that these cells contain [44] , which suggests that the enzyme still possesses significant housekeeping activity with regard to the maintenance of endogenous lysoPC levels.
Transient overexpression of iPLA 2 into COS cells has been found to significantly increase lysoPC levels without a concomitant increase in the incorporation of exogenous AA into phospholipids, suggesting that under these settings, lysoPC levels do not limit the initial rate of AA incorporation into phospholipids [25] . Since the results obtained in COS cells were performed in transiently transfected cells, it is possible that acute alterations in phospholipid metabolism induced by transient overexpression of iPLA 2 may not trigger normal physiological responses, as discussed elsewhere [45] . It is also possible that COS cells have a very limited capacity to incorporate AA into membrane phospholipids, and that the steady-state level of lysoPC in untrasfected cells is already high enough to account for a normal rate of incorporation of AA into the phospholipids of these cells. Thus, the excess amount of lysophospholipid produced by the iPLA 2 overexpressing cells would not be needed for AA incorporation.
Our results in phagocytic cells, together with those in COS [25] and pancreatic islet cells [44, 46] , appear to suggest that the mechanisms for lysophospholipid generation and the PLA 2 s involved in phospholipid fatty acyl chain remodeling may be cell-type specific. However, the results are also compatible with the hypothesis that a certain threshold level of intracellular lysophospholipid is necessary to support AA incorporation into phospholipids. In cells with a limited capacity of AA incorporation or in those with an exceedingly high steady-state lysophospholipid level, increasing and/or partially decreasing the intracellular level of lysoPC --by either iPLA 2 overexpression [25, 46] or pharmacological inhibition [44] , respectively--may have little or no effect on the initial rate of AA incorporation. Conversely, in cells specialized in AA metabolism such as phagocytes, decreasing [11, 12] or increasing (this work) the intracellular level of lysoPC may lead to significant changes in the initial rate of AA incorporation. Thus lysoPC-dependent regulation of AA incorporation into phospholipids may be strikingly characteristic of some cell types but not of others, and other factor(s) in addition to lysophospholipid availability may limit AA incorporation in certain cell types. reacylation/deacylation reactions and in non-specific fatty acid release during oxidant injury discussed above, a role for iPLA 2 in apoptosis has been suggested by the finding that apoptosis induction by either anti-Fas antibody or tumor necrosis factor plus cycloheximide in U937 cells is associated with iPLA 2 -mediated hydrolysis of membrane phospholipids [17, 18] . We have observed in this work that the extent of [18] have also noted that MAFP treatment of U937 cells does not prevent apoptosis in response to both anti-Fas antibody or tumor necrosis factor plus cycloheximide, although in this case, the drug was found to partially decrease apoptosis at early time periods. More recently, Lauber et al. [19] have reported that apoptosis of caspase-3-transfected MCF7 cells exposed to UV is not prevented by arachidonyl trifluoromethyl ketone. Although the latter result was taken by the authors to rule out a role for cPLA 2 in apoptosis [19] , arachidonyl trifluoromethyl ketone is also known to strongly inhibit iPLA 2 [47, 48] , which makes it likely that UV-induced apoptosis of caspase-3-transfected MCF7 cells is also independent of iPLA 2 [19] .
Collectively, all of the aforementioned examples suggest that, even though iPLA 2 may participate in the early phase of apoptosis under certain conditions, the enzyme may actually be dispensable for the apoptotic process to fully develop. It is therefore conceivable that, beyond a mere destructive role, iPLA 2 -mediated phospholipid hydrolysis during oxidant injury may serve to provide those accessory signals -e.g. eat me, or attraction signals-that are triggered along with the destructive process itself [49, 50] . Thus, products of iPLA 2 hydrolysis of cellular phospholipids during apoptosis, namely free fatty acids or perhaps lysophospholipids such as lysoPC [19, 51] , might be involved in providing these signals. Experiments are currently under way to test this possibility during oxidant-induced apoptosis.
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